Amedisys to Present at the Raymond James 33rd Annual Institutional Investors Conference
March 02 2012 - 10:50AM
Business Wire
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home
health and hospice companies, today announced that William F.
Borne, Chief Executive Officer, and Ronald A. LaBorde, President
and Chief Financial Officer, will present at the Raymond James 33rd
Annual Institutional Investors Conference in Orlando, FL on
Wednesday, March 7, 2012.
The presentation will begin at 8:40 a.m. Eastern. To access a
live webcast of the Amedisys presentation, please log on through
our website at http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. (NASDAQ: AMED) is a leading health care company
focused on bringing home the continuum of care. Amedisys delivers
personalized health care services to patients and their families in
the comfort of patients' homes. Amedisys care teams delivered 11
million patient care visits in 2011. Amedisys has two divisions,
home health care and hospice. The Company's state-of-the-art
advanced chronic care management programs and leading-edge
technology enables it to deliver quality care based upon the latest
evidence-based best practices. Amedisys is a recognized innovator,
being one of the first in the industry to equip its clinicians with
point-of-care laptop technology and referring physicians with an
internet portal that enables real-time coordination of patient care
seamlessly. Amedisys also has the industry's first-ever nationwide
Care Transitions program. Amedisys Care Transitions is designed to
reduce unnecessary hospital readmissions through patient and
caregiver health coaching and care coordination, which starts in
the hospital and continues throughout completion of the patient's
home health plan of care. For more information about the Company,
please visit: http://www.amedisys.com.
Our company website address is http://www.amedisys.com. We use
our website as a channel of distribution for important company
information. Important information, including press releases,
analyst presentations and financial information regarding the
Company is routinely posted on and accessible on the "Investor
Relations" subpage of our website, which is accessible by clicking
on the tab labeled "Investors" on our website home page. We will
also use our website to expedite public access to time-critical
information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and
Exchange Commission ("SEC") disclosing the same information. In
addition, we make available on the Investor Relations subpage of
our website (under the link "SEC filings") free of charge our
annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5
and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of
our Certificate of Incorporation and Bylaws, our Code of Ethical
Business Conduct and the charters for the Audit, Compensation and
Nominating and Governance Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Sep 2023 to Sep 2024